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Summary 
Major histocompatibility complex (MHC) class II (A~)  knockout mice were vaccinated with 
ts-4, an attenuated mutant strain of Toxoplasma gondii, which in normal animals induces strong 
T  cell immunity mediated by interferon ~/  (IFN-~). After challenge with the lethal parasite 
strain RH, the knockout mice displayed decreased resistance consistent with absence of CD4 + 
effectors. Nevertheless, these animals generated CD8 + lymphocyte effectors capable of mediat- 
ing partial protection through IFN-~ secretion. Morever, in vivo neutralization experiments 
indicated that the development of resistance in knockout mice depends on CD4 + cells as well 
as interleukin 2 (IL-2). The identity of the IL-2-producing protective cell population was fur- 
ther characterized as CD4 +, NKI.1 + by in vitro depletion studies and reverse transcriptase- 
PCR analysis of fluorescence-activated cell sorter (FACS)-purified CD4+NKI.1 § T  lympho- 
cytes. These results demonstrate that in the absence of conventional MHC class II-restricted 
CD4 + T lymphocytes, CD8 priming persists and mediates partial protective immunity to T. gondii. 
Moreover, the data argue that CD4 +, NK1.1 + cells, previously imphcated in the initiation of T 
helper cell 2 (Th2) responses through their production of IL-4, can also play a role as alterna- 
tive IL-2-secreting helper cells in Thl-mediated host resistance to infection. 
I 
nfection with the intracellular protozoan Toxoplasma gon- 
￿9  dii is characterized by an acute prohferative stage,  during 
which infective tachyzoites invade and rephcate within  a 
wide variety of  host cells, and a chronic slow growing phase 
consisting of parasite encystment within tissues of the brain 
and muscle (1, 2). Although infection is usually innocuous, 
in immunocompromised hosts encysted parasites  can reac- 
tivate, leading to uncontrolled tachyzoite prohferation, tis- 
sue damage, and encephalitis, which in some cases leads to 
host death (3, 4). 
To  investigate control of T.  gondii  infection, we  have 
employed a vaccine model in which mice are immunized 
with the  attenuated parasite mutant ts-4  (5).  When these 
animals are subsequently challenged with the highly viru- 
lent strain RH, vaccinated mice are completely protected, 
whereas nonvaccinated animals die within  10-14 d  (6-8). 
Vaccine-induced control of infection in normal mice has 
been shown to be dependent on three major elements: the 
cytokine IFN-~/, CD8 + T lymphocytes, and CD4 + lympho- 
cytes (6,  7).  CD8 §  cells  are likely to be  the  major,  and 
CD4 + T cells a secondary, source of IFN-~/, as determined by 
cell transfer and in vivo mAb neutralization studies (6, 9). 
However, CD4 cells play a pivotal role during induction of 
immunity, since administration of anti-CD4 mAbs during 
ts-4 vaccination prevents induction of a protective immune 
response (6). 
In the experiments reported here, we examined the abil- 
ity of MHC class II-negative mice, which have a targeted 
mutation in the A~ gene and therefore lack class II-restricted 
CD4 + T  lymphocytes (10-12), to generate protective im- 
munity to infection. We found that despite the absence of 
classic CD4 + T  cells in these animals,  CD8 + lymphocyte 
priming nevertheless continued to occur in response to ts-4 
immunization,  resulting in partial resistance  to RH  chal- 
lenge. Priming of CD8 + T  cells for effector function was 
found to require an early IL-2-dependent helper activity of 
a population of cells phenotypically defined as CD4+NKI.1 +. 
They therefore closely resemble a subpopulation of MHC 
class  II-independent  CD4+NKI.1 +  cells  that  is  selected 
during thymic differentiation by the  class 1-related mole- 
cule CD1  (13,  14) and produces several cytokines, in par- 
ticular IL-4, in response to anti-CD3  stimulation (15,  16). 
Our findings  demonstrate a role for NK1.1 + T  lymphocytes 
in resistance to infection in A[3 knockout animals and sug- 
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may also be a major functional activity of this cell popula- 
tion. 
Materials  and  Methods 
Mice and Parasites.  A[3  knockout  animals  (sixth  back-cross 
generation to C57BL/6), which express no surface MHC class II 
molecules,  were generated as previously described  (11) and sup- 
plied by GenPharm International (Mountain View, CA). Control 
C57BL/6 mice were obtained from The Jackson Laboratory  (Bar 
Harbor,  ME).  Mice were  maintained under specific pathogen- 
free  conditions and were  housed  under sterile  conditions, and 
cages were changed under a sterile hepa-filtered environment at 
the  National Institutes  of Health  animal facility.  Animals were 
routinely screened for infection with all  common adventitious 
pathogens.  Mice (6-8 wk of age) were immunized by biweekly 
intraperitoneal injection of 2 ￿  10 4, 2 ￿  10  5, and 2 ￿  I05 ts-4 ta- 
chyzoites.  2 wk after the final inoculation, resistance was evalu- 
ated by subcutaneous injection of 2,000  tachyzoites  of the viru- 
lent RH  strain.  The  latter  parasites,  as  well  as  the  attenuated 
mutant ts-4 (5), were maintained by weekly passsage at 37~  and 
34~  respectively, on monolayers of human foreskin fibroblasts. 
Ab Reagents.  Flow cytometric analyses employed the following 
mAbs (obtained from PharMingen, San Diego, CA):  PE-conju- 
gated 145-2C11 (anti-CD3); FITC-conjugated  RM4-5 (anti-CD4); 
FITC-conjugated  53-6.7  (anti-CDS);  PE-conjugated  H57-597 
(anti-oq3TCR); PE-conjugated GL3  (anti-~/STCR); PE-conju- 
gated  PK136  (anti-NKl.1); FITC-conjugated RA3-6B2  (anti- 
CD45R). In addition, mAb M5/114 (anti-class II) was obtained 
from Boehringer Mannheim Corp.  (Indianapolis,  IN).  In vivo 
depletion studies employed mAb XMG1.2 (anti-IFN-y), GK1.5 
(anti-CD4), 2.43  (anti-CD8), PK136 (anti-NKl.1), $4B6  (anti- 
IL-2), and PC61 5.3 (anti-IL-2 receptor). The mAbs were partially 
purified from mouse ascites by precipitation in 40% ammonium 
sulfate. For in vitro depletion, hybridoma supernatants containing 
the  mAbs  RL174.2  (anti-CD4),  SW3A4  (anti-NKl.l), RA3- 
3A1 (anti-B220),  orJllD (anti-B cell marker) were used. 
Flow Cytometric Analysis and Sorting.  Splenocyte  populations 
were analyzed  on a flow cytometer (Epics model 753;  Coulter 
Corp., Hialeah,  FL) as described in detail elsewhere  (17). In brief, 
red cells were lysed in hypotonic media, and the remaining cells 
were stained with mAbs in the presence  of saturating amounts of 
unlabeled 2.4G2  (anti-Fc receptor;  PharMingen), washed,  and 
then analyzed  in the  presence  of propidium iodide to  exclude 
dead  cells. To  obtain  highly  purified  populations  of  CD4  + 
NKI.1 + cells, splenocytes  from AI3 knockout mice injected 7 d 
previously with  2  ￿  104  ts-4  tachyzoites  were  passed over an 
anti-mouse Ig column according to the manufacturer's instruc- 
tions (R & D  Systems, Inc., Minneapolis, MN), resulting in an 
enriched  (>80%)  T  cell  population.  Cells  were  stained  with 
FITC-labeled anti-CD4 and PE-labeled anti-NK1.1. Cell sorting 
was performed on a FACStar sorter  (Beckton-Dickinson, Moun- 
tain View,  CA)  with  gates set  to  collect  double-positive cells 
(~0.4% of the total population). Immediately following sorting, 
cells were pelleted,  resuspended in RNazol (Tel-Test, Friends- 
wood, TX), and frozen in dry ice plus methanol to be processed 
later for reverse transcriptase (RT)*-PCR analysis of mRNA. 
~Abbreviations ttsed in  this paper: dNTP, deoxynucleotide triphosphate; 
HPRT, hypoxanthine  phosphoribosyl  transferase; RT, reverse transcriptase. 
In Vivo Cell and Lymphokine Depletion Experiments.  To assess the 
function of CD4 + and CD8 + lymphocytes as well as IFN-y in 
resistance to RH challenge,  mice were biweekly injected intra- 
peritoneally with 0.5 mg RL174.2, 0.25 nag 2.43, 2 mg XMG1.2, 
and 2 mg control mAb GLl13. Treatment commenced 3 d be- 
fore challenge infection and was continued for the duration of the 
experiment (30 d). The role of CD4 lymphocytes and IL-2 dur- 
ing vaccination was determined by biweekly injection of RL174.2 
(0.5 mg)  or a combination of $4B6 and PC61  4.5  (2 nag each). 
The mAbs were injected 3 d before the first ts-4 injection and 
throughout the vaccination regimen. Ab injection was halted 7 d 
after the final ts-4 injection, and 2 wk later, the mice were chal- 
lenged with RH strain parasites. 
In Vitro Cell Depletion and CD8 + Cell Purification.  To  eliminate 
CD4 + and NKI.1 §  cells from in vitro assays, splenocytes  were 
treated with two rounds of mAbs and rabbit complement (Accu- 
rate Chemical and Scientific Corporation, Westbury, NY) as pre- 
viously described  (17). To obtain purified populations of CD8 + 
lymphocytes, spleen cells were treated  with two rounds of mAb 
cocktail  plus  complement. The mAb cocktail  consisted  of mAb 
RL172.4,  SW3A4, RA3-3A1, and JllD  (18). After this  treat- 
ment, cells were passed over an anti-mouse Ig column according 
to the instructions of the manufacturer (R & D  Systems, Inc.). 
The resulting population of cells was  typically  >90% CD8 + as 
determined by flow cytometric analysis. 
Lymphokine Assays.  Responder CD8 + populations, obtained 
by treatment of splenocytes  with mAbs and complement, were 
added  to wells of a 96-well plate  (2  ￿  10S/well).  Splenic mac- 
rophages were obtained by incubating 108 normal spleen cells on 
a 100 X 15-ram petri dish (Falcon number 3803; Becton Dickin- 
son Labware,  Lincoln Park, NJ) for 1 h at 37~  removing non- 
adherent cells by washing with warm media, and then adding a 1  :  1 
ratio  of 15 kR-irradiated ts-4.  Infection was allowed to proceed 
overnight, and then adherent cells were  recovered by vigorous 
pipetting and washed  five  times  to  remove free  parasites  (con- 
firmed by microscopic  examination). Cells were irradiated  (2,000 
rads) and added  to responders  at 2  ￿  105 cells/well.  Presence  of 
IFN-3, in 72-h culture supernatants  of T. gondii  antigen-stimu- 
lated spleen cells was ascertained by a two-site ELISA (17) using 
as  a  standard  recombinant murine IFN-y  (Cetus  Corp.,  Em- 
eryville, CA). IL-2 release in supernatants stimulated for 24 h was 
quantitated with a CTLL proliferation assay (6). 
RT-PCR Detection of Cytokine mRNA.  To  detect  cytokine 
mRNA, an RT-PCR procedure was employed as described  in 
detail  elsewhere  (19). In brief,  RNA  was  isolated  from spleen 
cells by resuspending in RNAzol B (Tel-Test) and recovering the 
aqueous phase  after  addition of chloroform. RNA was precipi- 
tated with alcohol, washed,  and resuspended  in RNase-free H20. 
1 I.tg of RNA was reverse transcribed with Moloney murine leu- 
kemia virus RT (GIBCO BRL, Gaithersburg,  MD), deoxynucle- 
otide triphosphates  (dNTPs), and random hexamer primers.  The 
reaction mixture was then used for semiquantitative amplification 
of cytokine mRNA with Taq DNA polymerase  (Promega, Mad- 
ison, WI) and specific cytokine sense and antisense primers.  The 
numbers of amplification cycles were  as  follows:  23  (hypoxan- 
thine phosphoribosyl transferase [HPRT]), 29 (IL-4), and 35 (IL-2). 
The RT-PCR products were subsequently analyzed by Southern 
blotting followed by probing with internal cytokine gene-specific 
primers  and  an  enhanced  chemiluminescent detection  system 
(Amersham  International, Buckinghamshire, England). The  re- 
sults were subject to semiquantitative analysis by scanning densi- 
tometry followed by normalization to the HPRT standard as de- 
scribed elsewhere  (20-22). 
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cinated mice to lyse infected targets was determined as described 
(23). Effector CTL populations were generated by culturing im- 
mune splenocytes for 7 d in the presence of irradiated  (15 kl<) ts-4 
tachyzoites  at a cell-to-parasite  ratio of 7.5:1.  Bone marrow mac- 
rophages cultured 5-7 d in L cell media served as targets of CTL 
lysis. Cells were infected with ts-4 and then 18 h later were har- 
vested,  washed,  and labeled for 60 rain at 37~  with SlCr-labeled 
sodium chromate. After removal of unincorporated radioisotope, 
the macrophages were added to effector cells, and the assay was 
allowed to proceed for 4-5 h at 37~  Supematants  were collected 
with  a  supematant-harvesting  press  (Skatron  Instruments,  Lier, 
Norway),  and  radioactivity  was  compared  with  that  obtained 
with media alone and in the presence of 5% Triton X-100. The 
SEM of each sample, assayed in triplicate,  was consistently  <10%. 
Results 
Phenotypic Analysis of Splenocyte Populations in Normal and 
Ai8 Knockout Mice before and after ts-4 Immunization.  In ini- 
tial  experiments,  flow  cytometric  analysis  was  performed 
on  normal  and  ts-4-vaccinated  animals  to  ascertain 
whether  there  were  any  abnormalities  in  the  spleen  cell 
populations  of the  class  II  knockout  mice.  Splenocytes 
from  nonimmune  and  immune  A[3  knockout  animals 
showed a normal cell distribution except that,  as expected, 
virtually  no  cells  expressed  MHC  class  II molecules,  and 
there were correspondingly low levels ofCD4 + T  lympho- 
cytes (Table 1).  Importantly, NKI.1 + cells in AI3 knockout 
mice remained  at 3-4% of the splenocyte population after 
ts-4  immunization.  These  animals  therefore  differ  from 
CD8-negative  MHC  class  I  knockout animals,  which  re- 
spond to ts-4 vaccination with a large increase  in NKI.1 + 
cells (17). 
A[3  Knockout  Mice  Develop  CD8-dependent  Immunity  to 
RH Challenge.  To  assess  the  ability  of class  II-negative 
animals to develop protective immunity to T. gondii,  mice 
were vaccinated with ts-4, and survival was monitored after 
challenge with the virulent R.H strain.  As shown in Fig.  1 
A,  ts-4-vaccinated  wild-type  mice  were  completely pro- 
tected  from a  lethal  inoculum  of R.H.  In contrast,  vacci- 
nated  A[3  knockout  animals  developed  only partial  resis- 
tance to R.H challenge (Fig. 1 A). The degree of protection 
in these  mice was somewhat variable  from experiment  to 
experiment (e.g., compare Figs. 1, A  and B with 3 A); nev- 
ertheless, in all cases,  knockout animals succumbed by 60 d 
after challenge. 
We  and  others  have previously shown that  the  protec- 
tive response in normal mice is dependent mainly on IFN-~ 
produced by CD8 + T  lymphocytes and,  to a lesser extent, 
CD4 + T  lymphocytes (6, 7, 17). To determine the basis for 
protection in the class II-negative mice, animals were vac- 
cinated and then treated with depleting mAbs at the time of 
challenge infection. As in the case of normal animals, ts-4- 
induced immunity is IFN-y dependent, since knockout ani- 
mals  treated  with  mAbs to the  latter  cytokine  died  at the 
same time as, or slightly before, nonvaccinated mice (Fig. 1 B). 
In control experiments,  administration of anti-IFN-y mAb 
to  uninfected  mice  caused no  deaths  over the  same  time 
period, indicating that mortality was induced by inabihty to 
control  T. gondii infection rather than the activation of an 
endogenous  pathogen  harbored  by  the  animals.  We  also 
observed  a  slightly  accelerated  time  to  death  in  IFN-'y- 
depleted vaccinated mice relative to that in nonvaccinated 
and CD8-depleted animals. This observation may reflect neu- 
tralization  of NK cell-derived  IFN-',/, since these  cells are 
also a source of the latter cytokine during  T. gondii infec- 
tion, particularly during the initial phase of the disease  (21, 
24). In addition, anti-CD8 mAbs completely abrogated pro- 
tection,  but  anti-CD4  treatment  had  no  significant  effect 
relative to mice given control mAbs (Fig.  1 B). Together, 
these  results  suggest  that  IFN-~/  produced  by  immune 
CD8 §  T  cells  provides protection in the  class  II-negative 
animals. 
The presence  of primed  CD8 +  effector cells  in the  ab- 
sence of class II-restricted helper cells was directly tested in 
vitro by CTL assays on infected macrophages and cytokine 
production  induced  by  infected  macrophages.  In  killing 
assays, the ability to lyse SlCr-labeled infected targets has pre- 
viously been shown to be a function of  MHC class I-restricted 
immune  CD8 +  effector cells  induced by ts-4  vaccination 
(23,  25).  As shown in Fig. 2 A, lysis  was equivalent using 
effector CTLs from wild-type and knockout mice.  In nei- 
ther case were effectors able to lyse nonmfected macrophages. 
Moreover,  when  CD8 +  T  cells  from vaccinated  animals 
Table 1.  Phenotypic  Analysis of Splenocyte Populations in Wild-type and Ai8 Knockout Mice 
Cells per spleen (￿  10 -7) expressing* 
Mouse  Genotype  CD3  CD4  CD8  ocI3TCR.  3,STCR-  NKI.1  B220  I-A 
Normal  A[3  +/+  4.16  2.37  1.79  4.08  0.13  0.47  5.03  4.85 
A~  -/-  4.10  0.54  3.47  3.70  0.26  0.69  8.48  0.22 
Immune*  Af3 +1+  8.40  3.91  4.15  7.97  0.69  0.65  13.32  12.48 
A[3  -/-  8.32  1.37  6.92  8.32  1.06  1.01  16.38  0.31 
*  Spleen cells were examined for expression of the indicated surface markers by flow cytometric analysis. 
*Animals were vaccinated three times with the attenuated mutant ts-4, and spleen cells were recovered for analysis 2 wk later. 
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Figure 1.  Immunization of A[3 knockout mice with ts-4 results in par- 
tial resistance  to P,.H challenge and is dependent on CD8 + T lymphocytes 
and IFN-~. In A, groups of 6-10 knockout and wild-type mice were vac- 
cinated intraperitoneaUy  with ts-4 tachyzoites and challenged subcutane- 
ously with the virulent strain RH, and their survival  was monitored. In B, 
knockout mice (six to eight per group) were vaccinated with ts-4, then 
treated with the indicated mAb initiated 3 d before RH challenge. See 
Materials  and Methods section for details. The figure shows pooled results 
from two experiments. 
were  purified and  cultured with  infected stimulator cells, 
the  levels  of IFN-~/  released were  similar in  normal  and 
class  II  knockout  mice  (Fig.  2  B).  Addition of blocking 
anti-CD8  mAb to the cultures reduced cytokine levels to 
levels  stimulated  by  uninfected  macrophages,  confirming 
that the IFN-~ measured was indeed derived from CD8 + 
T  lymphocytes. 
Priming  of CD8 +  Cells for IFN-'y  Production  Depends  on 
CD4 +, NK1.1 + Cells and IL-2.  We were surprised to find 
that  A[~  knockout  mice  were  able  to  generate  effector 
CD8 + T  lymphocytes, as it is generally believed that prim- 
ing of the latter cell population requires help in the form of 
IL-2 from MHC  class II-restricted CD4 + lymphocytes (6, 
26-28),  cells that  are absent in A[3  knockout  animals  (10, 
11).  Nevertheless, a  novel population of CD4+NKI.1 + T 
cells has  been  described that  differentiates in  dependence 
upon  the  class  I-like molecule  CD1  rather  than  classical 
MHC  class II proteins (13, 14). While the function of these 
cells during infection is unknown,  they have  been shown 
to produce a number of cytokines in response to anti-CD3 
stimulation (15, 16). 
The above considerations prompted us to investigate the 
factors involved in priming CD8  cells for IFN-~/produc- 
tion in the absence of class II-restricted CD4 cells. Accord- 
ingly, animals were  administered mAbs to  CD4  and  IL-2 
during the  ts-4  vaccination period,  treatment  was  halted, 
mice were RH  challenged, and survival was noted. When 
class II knockout animals were given mAbs to IL-2 and its 
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Figure 2.  In vitro effector functions of CD8 + cells are unaltered in 
MHC class II knockout animals. Mice were immunized with ts-4 as in 
Fig. 1; 2 wk later, spleen cells  were isolated, cultured with irradiated  tachy- 
zoites for 7 d, and then tested for CTL function by their ability to lyse 
syngeneic infected target macrophages labeled with  StCr (.4). In vitro 
IFN-~/production was measured by culturing immune CD8 + T lympho- 
cytes (obtained by treatment with a cocktail of anti-NKl.1, anti-CD4, 
and anti-B cell mAbs and complement, followed by passage over T cell 
purification columns) with  ts-4-infected  macrophages with  or without 
blocking levels of anti-CD8  rnAb to confirm the source of cytokine as 
CD8 + cells. After 72 h, supematants were collected and tested for IFN-~/ 
by a two-site sandwich ELISA as described in detail in Materials and 
Methods. This experiment was repeated three times with similar results. 
receptor or,  more  interestingly, CD4  during vaccination, 
the  animals showed  a  complete loss of resistance to  chal- 
lenge (Fig. 3 A). This contrasted with the result when anti- 
CD4  was  given after vaccination, in which  case the mAb 
had no significant effect (see Fig. 1 B). As previously shown 
(6), immune C57BL/6  mice given anti-CD4 but not anti- 
IL-2 mAbs during vaccination failed to control 1LH infec- 
tion, and all mice died between 19 and 21  d after challenge 
(Fig. 3 B). 
We  next  examined the  ability of CD8 +  cells from A~ 
knockout  and wild-type mice  to  produce  IFN-'y in vitro 
after mAb  treatment  during vaccination. Parasite antigen- 
induced  cytokine  production  from  A[3  knockout  CD8 + 
cells was  blocked  by in  vivo  administration  of anti-CD4 
(89%  inhibition), anti-NKl.1  (78%  inhibition),  and  anti- 
IL-2 (93% inhibition) (Fig. 4 A). These results suggest that 
induction of CD8 +  effector T  lymphocytes in  the knock- 
out  animals  requires,  in  addition to  parasite antigen,  cells 
expressing CD4 and NKI.1, as well as a source of IL-2. In 
the wild-type situation (Fig. 4  B), where CD8  T  lympho- 
cyte priming  occurs  in  the  presence  of class  II-restricted 
CD4 cells, anti-CD4 mAb treatment again abrogated IFN-~/ 
production  by  CD8 +  cells  (84%  inhibition).  In  this  case, 
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Figure 3.  Induction of  immunity in AI~ knockout mice requires MHC 
class lI-independent CD4 +  cells and  IL-2.  During  ts-4  vaccination, 
knockout  (A) and wild-type  (B) mice were  treated with the indicated 
mAbs. After the final vaccination, mAb treatment was halted, and 2 wk 
later, animals were challenged with R.H strain tachyzoites. At the time of 
challenge, efficacy of CD4 depletions was confirmed by FACS  |  analysis 
(0.1% for both wild-type and knockout vs. 16.3 and 1.9% in control A~- 
treated animals). The data shown were pooled from two independently 
performed experiments. 
however,  anti-NKl.1  treatment  had  only  a  partial effect 
(32%  inhibition),  and  anti-IL-2  administration  failed  to 
block CD8 priming for IFN-'y production. 
IL-2 Is Produced Early after ts-4  Vaccination.  The  data  in 
Figs. 3  and 4  suggested that the IL-2 required for CD8 + T 
lymphocyte priming in AB knockout animals was derived 
from cells expressing the CD4 and NKI.1 markers. Indeed, 
when either wild-type or knockout animals were injected 
intraperitoneaUy with ts-4, IL-2 was produced when sple- 
nocytes  were  restimulated in  vitro  with  irradiated tachy- 
zoites. The  response was  detectable after 4  d  and reached 
peak  levels  7  d  after  infection  (Fig.  5  A).  Interestingly, 
when mice were boosted with ts-4 on day 14 and then ex- 
amined for IL-2 production 3  d later, wild-type mice pro- 
duced high levels, whereas the class II knockout mice pro- 
duced httle of this cytokine (Fig. 5  B). This result suggests 
that two sources of IL-2 are available, one acting early in an 
MHC  class II-independent fashion, and another  (presum- 
ably conventional CD4 + T  lymphocytes) requiring class II 
molecules  and  acting  later.  Wild-type  animals  therefore 
possess both of these activities, and the AJ3 knockout mice 
only have the early class II-independent source. 
NK1.1+ CD4 + T  Lymphocytes Produce IL-2 in Response to 
Parasite Stimulation.  To determine the source of early IL-2 
produced in the parasite-stimulated ~ultures of both wild- 
type and knockout animals, C57BL/6  mice were infected, 
and  7  d  later,  spleen ceils were  isolated and  treated with 
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Figure 4.  Priming of CD8 + T lymphocytes for IFN-'y production is 
blocked by treatment with mAbs to CD4, NKI.1, and IL-2 during ts-4 
vaccination in MHC class  II knockout mice. AI3 knockout (.4) and wild- 
type (/3) animals were vaccinated and simultaneously treated with the in- 
dicated mAbs. 2 wk after the final injection, spleen cells  were isolated, and 
CD8 + lymphocytes were purified by treatment with two cycles of anti- 
CD4, anti-NKl.1, and anti-B cell mAbs plus complement, followed by 
passage over an anti-lg T cell purification column. The latter cells (>90~ 
CD8 § as determined by FACS  |  analysis) were then cultured with irradi- 
ated normal and infected macrophages, and IFN-~/release was measured 
by two-site ELISA. This experiment was performed three times with the 
same result. 
moval of either CD4 + or NKI.1 + cells in this manner elim- 
inated the ability to produce IL-2 in response to tachyzoite 
stimulation (Fig. 6), indicating that cells expressing the lat- 
ter markers are a source of IL-2 in these cultures. The ob- 
servation that  either  anti-CD4  or anti-NKl.1  completely 
abohshed  IL-2 production suggested that a  single popula- 
tion of cells coexpressing the latter markers were responsi- 
ble for cytokine secretion. Indeed, flow cytometric analysis 
revealed  a  subpopulation  of cells  in  both  knockout  and 
wild-type animals expressing both CD4 and NK1.1  (Fig. 7, 
A  and B). The latter cells were present at "-'0.6 and 0.9% of 
the total splenocyte population, or 2.4 and 19.9% of CD4 + 
lymphocytes,  in  normal  and  knockout  animals,  respec- 
tively. These percentages were equivalent in both infected 
and  noninfected A[3 knockout mice  (Fig. 7  C)  and wild- 
type  (data not  shown)  mice.  In contrast,  we  failed to  see 
this small subpopulation when spleen cells from 132-micro- 
globuhn-negative mice were examined (Fig. 7 D). The tat- 
ter result was expected on basis of the fact that NKI.1 + T 
cells require CD1  for their positive selection during thymic 
maturation (13,  14). 
To directly determine whether the double-positive cells 
produced cytokines after infection, spleen cells from non- 
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Figure 5.  IL-2 is produced by spleen cells early after tachyzoite injection in normal and knockout mice. In A, groups of four animals were injected in- 
traperitoneally with 2 ￿  10  4 ts-4 tachyzoites, and then at the indicated days after injection, spleens were removed from each group, and cells were cul- 
tured in the presence of irradiated tachyzoites for 24 h. IL-2 release was measured by the ability of the supernatants to stimulate proliferation (measured by 
[3H]TdR. incorporation) of IL-2-responsive CTLL cells. In B, after 14 d mice were reinjected with ts-4 (2 ￿  105 tachyzoites), and then 3 d later, spleen 
cells were removed and parasite-induced IL-2 production was measured. 
infected  and  day  7  T. gondii-infected  A[3  knockout mice 
were  stained  for  CD4  and  NKI.1;  then  highly  purified 
double-positive cells were  isolated by flow cytometric cell 
sorting,  and  gene  transcripts were  analyzed by RT-PCIL. 
The  results  shown  in  Fig.  8  demonstrate  that  CD4  + 
NKI.1 +, but not CD4+NKI.1 -,  T  lymphocytes from in- 
fected  class  II  knockout  animals  produce  IL-2  mtLNA, 
whereas as little or none was detected when cells from un- 
infected animals were examined. Interestingly, CD4 + NK1.1 § 
cells  appeared  to  be  downregulated  for  IL-4  at  the  same 
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Figure  6.  Early IL-2  production is abrogated  by removal  of either 
CD4 + or NKI.1 + cells before culture. C57BL/6 mice were injected in- 
traperitoneally with 2 ￿  10  s ts-4 tachyzoites. Spleen cells were isolated 7 d 
after injection,  treated with the indicated mAbs plus complement,  and 
cultured in the presence or absence of irradiated tachyzoites as parasite an- 
tigens. Trypan blue exclusion and FACS  |  analysis at culture  initiation 
confirmed cell viability and depletion specificity. After 24 h, supernatant 
was collected and tested for IL-2 by a CTL bioassay. See Materials and 
Methods  for  experimental  details. This experiment  was  repeated  three 
times with the same result. 
time as being upregulated for IL-2 production as a  conse- 
quence of T. gondii infection, although the  significance of 
this  finding  awaits  a  more  detailed  investigation.  Thus, 
CD4+NKI.1 + T  lymphocytes are induced to produce IL-2 
in response  to  T. gondii infection, and the levels made are 
sufficient to  lead to  priming of CD8 +  T  lymphocytes  for 
effector function. 
Discussion 
The results of this study demonstrate that class II knock- 
out mice are able to generate partial immunity to challenge 
with a virulent T. gondii strain after vaccination with an at- 
tenuated  mutant.  The  protective  response,  similar to  that 
occurring in wild-type animals, was dependent on CD8 + T 
lymphocytes  and  IFN-%  Establishment  of protective  im- 
munity required IL-2 and, interestingly, CD4 §  cells during 
the vaccination period.  Similarly, generation of CD8 + cells 
capable  of parasite  antigen-specific  IFN-y  production  in 
vitro required IL-2, CD4 +, and NKI.1 §  cells.  IL-2 secre- 
tion in vitro was detected by use of splenocytes early after 
ts-4 vaccination, and its production was dependent on cells 
expressing  CD4  and  NKI.1  surface  molecules.  Finally, 
FACS|  CD4+NK1.1 + cells from vaccinated animals 
were directly shown to constitutively express IL-2 mRNA, 
in contrast with CD4+NKI.1 § cells from nonimmune mice. 
While these results are based on negative depletion data 
rather  than transfer of positively selected  cell populations, 
the  data  nonetheless lead us  to  the  conclusion that  in A[3 
knockout  mice,  CD4+NKI.1 §  T  lymphocytes  serve  as  a 
source of IL-2 that primes CD8 § ceUs for effector function. 
As  such,  our findings provide  the  first  evidence  that  this 
novel T  lymphocyte population plays an important role in 
resistance to infection by virtue of its ability to produce IL-2. 
Recent studies have shown that the CD4+NKI.1 §  pop- 
ulation  possesses  several  unique  immunologic  properties. 
First, MHC  class II molecules are not used for their selection 
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Figure  7.  Presence of NKI.I+CD4  + T  cells in spleens of wild-type 
and A[3 knockout mice. Individual  spleens (four per group) of  MHC class 
I1 knockout mice (A), wild-type mice (B), ts-4-infected knockout mice at 
7 d  (C), and J32-microglobulin knockout mice (D) were stained with 
FITC-conjugated anti-CD4 mAb and PE-conjugated anti-NKl.1  mAb, 
then examined by flow cytometric analysis. The data shown are from one 
representative spleen of  each mouse strain. 
Figure  8.  P,T-PCR  analysis 
of  sorted  cells  reveals  that 
NKI.I+CD4  +  T  cells produce 
IL-2 mKNA after T. gondii in- 
fection.  T  lymphocytes from 
noninfected (-) and 7 d infected 
(+)  MHC  class  II  knockout 
mice,  purified by  passage of 
spleen  cells over an anti-Ig col- 
umn,  were stained with  F1TC- 
conjugated anti-CD4  mAb and 
PE-conjugated anti-NKl.1 mAb; 
then CD4+NKI.1 + and CD4 +- 
NKI.1- cells were collected by 
flow  cytometric sorting.  After 
RNA  purification  and  reverse 
transcription to cDNA, mRNA 
for IL-2, IL-4, and HPRT was 
assessed by PCR followed by Southern blotting. A semiquantitative anal- 
ysis of  two experiments by scanning  densitometry followed by normaliza- 
tion to HPKT revealed the following fold increases or decreases relative 
to cells from noninfected mice: 9.4, 11.9 (IL-2 from CD4+NKI.I+);  1.3, 
1.9 (IL-2 from CD4+NKI.1-); 0.1, 0.5 (IL-4  from CD4+NKI.I+); and 
1.2, 1.1  (IL-4 from CD4+NKI.1-).  See Materials and Methods for de- 
tails. 
during thymic ontogeny, but rather this function is provided 
by the class l-like molecule CD1 (composed ofa non-MHC- 
encoded  heavy  chain  associated  with  a  [32-microglobulin 
light  chain)  (14).  Second,  they express  the  surface marker 
NKI.1,  a  molecule  normally  associated  with  the  natural 
killer  lineage  (13,  29).  Third,  while  CD4  + NKI.1 +  cells 
express the oL[3 TCR, VJ38,  7, and 2 fanfilies are over-rep- 
resented  (13,  16),  and ot chain usage is restricted to Vcx14- 
J281  (30). Finally, T  cells coexpressing CD4 and NKI.1 are 
able to secrete  a diverse  array of lymphokines,  and in par- 
ticular,  early IL-4 production  has  been shown  to be  trig- 
gered by injection of anti-CD3 mAbs (15,  16).  It has been 
suggested  that  this  novel population  of cells  may provide 
the  early  source  of IL-4  necessary  to  drive  immune  re- 
sponses  toward  a  type  2  (high  IL-4/low IFN-'y) cytokine 
production pattern, as occurs in helminth infections (15, 31). 
While  NKI.1 §  T  cells  have been  described  as  a potent 
early  source  of IL-4  (15),  our  data  reveal  that  during  T. 
gondii infection, cells of the same surface phenotype are up- 
regulated  for IL-2 production.  Although it is possible  that 
the NK1.1 + T  lymphocytes detected here are a population 
distinct  from  those  previously  described,  this  is  unlikely, 
because  the  T. gondii-induced  cells  also  appear  to  have  a 
skewed  repertoire  of expressed  TCR  genes  (Denkers,  E., 
unpublished observations).  Instead, we favor the hypothesis 
that  these  cells  initially  produce  IL-4,  but  that  infection 
drives them toward a dominant IL-2 response.  In this con- 
text, it is noteworthy that T. gondii is also a potent early in- 
ducer ofmacrophage IL-12, which selectively drives type 1 
responses  (21,  24,  32).  In addition,  the  parasite  contains  a 
superantigen  activity that  can induce  IFN-~/ directly from 
naive  CD8  cells  (18).  Thus,  in the case of T. gondii infec- 
tion,  cytokines inducing both type  1 and type 2  responses 
would be  expected  early on,  but  the  immunomodulatory 
effects of the former appear to cross-regulate the latter.  Sup- 
port for this view comes from the observation that during 
early infection with the cyst-forming strain ME49,  IL-4 is 
one of the first cytokines induced but subsequently disap- 
pears (33). Moreover, in IFN-~/knockout mice, IL-4 is over- 
produced during early ts-4 and ME49 infection (Scharton- 
Kersten, T., manuscript in preparation). 
Previous  work from our laboratory indicates  that  mAb 
depletion  of CD4 +  cells  in  wild-type  mice  abrogates  the 
ability to generate  CD8 + immunity (6).  The results  of the 
present  study show that in  the  absence  of MHC  class  II- 
restricted  CD4 +  lymphocytes,  T  helper  function  is  pro- 
vided by nonconventional CD4 § cells through the produc- 
tion of IL-2. However, in normal mice,  depletion  of IL-2 
with  mAb had no  effect on the  ability to  generate  CD8 + 
immunity.  While  it is possible  that the levels of IL-2 pro- 
duced in normal mice are high enough that mAb neutral- 
ization is incomplete,  this would seem unlikely,  given that 
the  mice  were  given a  combination  of mAbs to  the  IL-2 
receptor and the cytokine itself.  In addition, while it is for- 
really possible that wild-type mice produce neutralizing an- 
tibodies  to  the  anti-cytokine  mAb,  this  would  seem  un- 
likely,  because  the  other  rat  mAbs  given  were  highly 
effective in the wild-type mice used in this study. A  more 
interesting possibility is that an alternative  source of prim- 
ing lymphokine is available in MHC  class II-positive mice, 
most likely produced in dependence on CD4 + T  lympho- 
cytes. In this regard, it is noteworthy that IL-15, a cytokine 
with many of the properties oflL-2, is induced during mu- 
rine  T. gondii infection (22). 
We  previously  examined  the  response  of MHC  class 
I-negative mice to ts-4 vaccination and RH  challenge (34). 
In that study,  and similar others  (35),  an overexpansion of 
protective  IFN-~/-producing NK cells,  induced as  a  result 
of infection,  appears  to  compensate  for  genetic  loss  of 
IFN-~-producing CD8 + lymphocytes. It was of interest to 
137  Denkers  et al. note in the present study that lack of  MHC class II-restricted 
CD4 +  T  lymphocytes,  another  major  source  of IFN-'y 
during T. gondii infection (6, 21, 36), is not sufficient to in- 
duce overexpansion of NK cells.  These data lend support, 
although somewhat indirect,  to the hypothesis that CD8 +, 
but  not  classical  CD4 +,  T  lymphocytes  are  involved  in 
downregulation  of NK  cell  responses  during  infection  of 
normal mice (35, 37, 38). 
The  molecular  basis  for activation  of CD4+NKI.1 +  T 
lymphocytes is presently not understood, but the class I-like 
molecule appears to be involved (39).  In addition,  the re- 
stricted  repertoire  of  TCR  genes  expressed  by  CD4  + 
NK1.1 + T  cells suggests a limited capability of recognizing 
antigen  (13,  14, 30,  40).  Although CD1  is able to present 
certain  peptides,  as  well  as  nonconventional  lipid  Ag,  to 
mouse and human T  cells (41-43),  the molecule alone ap- 
pears  to be sufficient to activate NKI.1 + T  cells  (14,  44). 
Thus, while the CD1 molecule is expressed at low levels in 
the spleen (14), its controlled upregulation could be the ba- 
sis for NKI.1 + T  cell activation.  Indeed,  preliminary evi- 
dence from our laboratory suggests that  T. gondii infection 
induces elevated expression of CD1 in infected mice (Den- 
kers, E., unpublished observations). 
The finding that  T. gondii infection triggers  NKI.1 +  T 
lymphocytes  during  early  infection  provides  important 
clues regarding the role of these cells and their regulation in 
microbial pathogenesis. While these cells were initially de- 
scribed as an early IL-4 source involved in type 2 response 
initiation,  our results show that this is not their sole func- 
tion,  that in the  absence of class  lI-restricted  CD4 +  cells, 
they are  crucial  for induction  of CD8 +  T  cell  responses. 
The  Toxoplasma  murine  model should provide  a  valuable 
system for analyzing both the molecular basis of microbial 
recognition  by  CD4+NKI.1 +  T  lymphocytes  and  the 
events involved in their triggering. 
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